Momentum
Relative Strength (%)
1m
3m
1yr
Volume Change (%)
10d v 3m
Price vs... (%)
52w High
50d MA
200d MA
vs.
market
vs.
industry
Growth & Value

Margin of Safety (beta)
Screens Passed 3
Balance Sheet · Income Statement · Cashflow Financial Summary
Year End 31st Dec 2008 2009 2010 2011 2012 2013 2014E 2015E CAGR / Avg
Revenue £m
Operating Profit £m
Net Profit £m
EPS Reported p
EPS Normalised p
EPS Growth %
PE Ratio x
PEG x
Profitability
Operating Margin %
ROA %
ROCE %
ROE %
Cashflow
Op. Cashflow ps p
Capex ps p
Free Cashflow ps p
Last ex-div: 4th Jun, paid: 2nd Jul more... Dividends
Dividend ps p
Dividend Growth %
Dividend Yield %
Dividend Cover x
Balance Sheet
Cash etc £m
Working Capital £m
Net Fixed Assets £m
Net Debt £m
Book Value £m
Average Shares m
Book Value ps p +11.0%

FINANCIAL BRIEF: For the fiscal year ended 31 December 2013, Bioquell plc revenues increased 9% to L44.6M. Net income decreased 24% to L3.1M. Revenues reflect Bio-decontamination segment increase of 7% to L27.9M, Testing segment increase of 11% to L16.8M, Rest of World segment increase of 13% to L15.7M, United Kingdom segment increase of 9% to L20.2M, Rest of Europe segment increase of 3% to L8.8M. more »

Health Trend

Bankruptcy Risk

  Earnings Manipulation Risk

Magic Formula Score
B-
B-

Other Ratios
Leverage (ttm) Total Ex Intang
Gross Gearing %
Net Gearing %
Cash / Assets %

vs.
market
vs.
industry
Recent History
Latest interim period (ended 31st Dec '13) vs. prior year
Sales Growth %
EPS Growth %
3yr Compound Annual Growth Rate
Sales Growth %
EPS Growth %
DPS Growth %

Broker Forecasts
31st Dec 2014
31st Dec 2015

Price Target: 152 (+21.61% above Price) Net Profit EPS DPS Net Profit EPS DPS
Est. Long Term Growth Rate: +28.0% (£) (p) (p) (£) (p) (p)
Consensus Estimate
1m Change
3m Change
2 brokers Broker Consensus Trend
Broker Recommendations for Bioquell
Recommendation:Strong SellSellHoldBuyStrong Buy
No. of Analysts: 0 0 1 1 0

Named Brokers and Analysts
Investec Bank (UK) Plc Nicholas Keher , N+1 Singer Elizabeth Klein ,

Bioquell PLC is a holding company. It is engaged in the principal activities of designing, manufacturing and supplying of bio-decontamination and containment equipment, related products and services to the healthcare, life sciences and defense industries, and testing, regulatory and compliance services to a range of companies, including the aerospace, telecoms and defense industries. It has two divisions: bio-decontamination (BIO) division is engaged in providing solutions based on hydrogen peroxide vapor technology to eradicate bacteria, viruses and fungi, throughout a range of applications. It also provides chemical, biological, radiological and nuclear defense filtration technology and specialist laboratory filtration equipment, and the TRaC (Testing, Regulatory and Compliance) division provides a range of services that include environmental testing, telecoms testing, radio testing, electromagnetic compatibility testing, safety testing, CE Mark testing and stress analysis.

Directors: Nicholas Adams (CEO) , Michael Roller (Fin. Dir.) 46, Georgina Pope (Secy.) ,

No. of Employees: 449 No. of Shareholders: n/a


Last Annual December 31st, 2013
Last Interim December 31st, 2013
Shares in Issue 42,432,427
Free Float 20.5m (48.3%)
ISIN GB0004992003
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index FTSE Fledgling , FTSE Fledgling XIT,
Exchange London Stock Exchange (Full)
Eligible for an ISA? a SIPP?

BQE Share Price Performance BQE Quote
124.5p
0.0  0.0%
Traded 1:58pm · Minimum 15 min delayed · NMS: 1.50k

Latest BQE News Announcements (delayed)

Upcoming BQE Events
Wednesday 4th June, 2014
Dividend For BQE.L

Recent ↓
Tuesday 18th March, 2014
Preliminary 2013 Bioquell PLC Earnings Release
Friday 17th January, 2014
Bioquell PLC Pre-Close Update on the year ended 31 December 2013
Friday 15th November, 2013
Bioquell PLC Interim Management Statement
Wednesday 28th August, 2013
Interim 2013 Bioquell PLC Earnings Release
Wednesday 5th June, 2013
Dividend For BQE.L
Monday 13th May, 2013
Bioquell PLC Annual General Meeting
Monday 13th May, 2013
Bioquell PLC Interim Management Statement for the period ended 12 May, 2013
Tuesday 19th March, 2013
Preliminary 2012 Bioquell PLC Earnings Release
Monday 14th January, 2013
Bioquell PLC Pre-close Update
Friday 16th November, 2012
Bioquell PLC Interim Management Statement


Use of our data service is subject to express Terms of Service. Please see our full site disclaimer for more details. In particular, it is very important to do your own research (DYOR) and seek professional advice before making any investment based on your own personal circumstances. Please note that the information, data and analysis contained within this stock report: (a) include the proprietary information of Stockopedia's third party licensors and Stockopedia; (b) should not be copied or redistributed except as specifically authorised; and (c) are not warranted to be complete, accurate or timely. You should independently research and verify any information that you find in this report. Stockopedia will not be liable in respect of any loss, trading or otherwise, that you may suffer arising out of such information or any reliance you may place upon it. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up. © Stockopedia 2014.


Should you buy BQE

Access BQE Analytics Now!

FREE TRIAL or TAKE THE TOUR